Insider trades

Steven Gannon, Director of Xenon Pharmaceuticals XENE, has filed 0 purchases and 5 sales on the open market. The latest trade was on 06/03.

Steven Gannon

Director
First filing
23/06/02
Trades
25 trades
Buys / sales
0 / 5
12-month net buying
No record
Last trade
06/03

Trading activity

Transactions

Trade type
Open-market sale25/06/0525/06/063 sh$30.48$91.44−0.0%
XENE
Open-market sale24/03/0724/03/0813,000 sh4 trades$46.28avg.$601,600−86.7%